BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 3035894)

  • 21. Localization of angiotensin AT1 and AT2 receptors.
    Allen AM; Zhuo J; Mendelsohn FA
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S23-9. PubMed ID: 9892137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central and peripheral distribution of corticotropin-releasing factor.
    Petrusz P; Merchenthaler I; Maderdrut JL; Heitz PU
    Fed Proc; 1985 Jan; 44(1 Pt 2):229-35. PubMed ID: 3871410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central nervous system effects of the neurohypophyseal hormones and related peptides.
    de Wied D; Diamant M; Fodor M
    Front Neuroendocrinol; 1993 Oct; 14(4):251-302. PubMed ID: 8258377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II in the central nervous system in the rat.
    Simonnet G; Legendre P; Carayon A; Allard M; Cesselin F; Vincent JD
    J Physiol (Paris); 1984; 79(6):453-60. PubMed ID: 6100309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of corticotropin-releasing factor in the pathogenesis of major depression.
    Nemeroff CB
    Pharmacopsychiatry; 1988 Mar; 21(2):76-82. PubMed ID: 3293091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the neuroendocrine role of serotonin.
    Jørgensen HS
    Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The renin-angiotensin system and the central nervous system.
    Ganong WF
    Fed Proc; 1977 Apr; 36(5):1771-5. PubMed ID: 191299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats.
    Wilson MA; Biscardi R; Smith MD; Wilson SP
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1073-82. PubMed ID: 8819488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain angiotensin II, an important stress hormone: regulatory sites and therapeutic opportunities.
    Saavedra JM; Ando H; Armando I; Baiardi G; Bregonzio C; Jezova M; Zhou J
    Ann N Y Acad Sci; 2004 Jun; 1018():76-84. PubMed ID: 15240355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
    Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
    Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain.
    Owens MJ; Bissette G; Nemeroff CB
    Synapse; 1989; 4(3):196-202. PubMed ID: 2575286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role and action in the pituitary corticotroph of corticotropin-releasing factor (CRF) in the hypothalamus.
    Kageyama K; Suda T
    Peptides; 2009 Apr; 30(4):810-6. PubMed ID: 19124055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the role of angiotensin II in mediation of adrenocorticotropin secretion.
    Plotsky PM; Sutton SW; Bruhn TO; Ferguson AV
    Endocrinology; 1988 Feb; 122(2):538-45. PubMed ID: 2828001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative autoradiography of angiotensin II receptors in brain and kidney: focus on cardiovascular implications.
    Gehlert DR; Speth RC; Wamsley JK
    Prog Clin Biol Res; 1985; 192():241-9. PubMed ID: 3001756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticotropin-releasing factor receptors: autoradiographic identification.
    De Souza EB; Kuhar MJ
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():179-98. PubMed ID: 3014625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems.
    Brown MR; Fisher LA
    Fed Proc; 1985 Jan; 44(1 Pt 2):243-8. PubMed ID: 2981744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological actions of angiotensin II mediated by AT1 AND AT2 receptors in the brain.
    McKinley MJ; McAllen RM; Pennington GL; Smardencas A; Weisinger RS; Oldfield BJ
    Clin Exp Pharmacol Physiol; 1996 Sep; 23 Suppl 3():S99-104. PubMed ID: 21143281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and regulation of angiotensin II receptors in pituitary, circumventricular organs and kidney.
    Mendelsohn FA; Aguilera G; Saavedra JM; Quirion R; Catt KJ
    Clin Exp Hypertens A; 1983; 5(7-8):1081-97. PubMed ID: 6315266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anatomy of the corticotropin-releasing factor and opiomelanocortin systems of the brain.
    Joseph SA; Pilcher WH; Knigge KM
    Fed Proc; 1985 Jan; 44(1 Pt 1):100-7. PubMed ID: 2981728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain and pituitary receptors for corticotropin releasing factor: localization and differential regulation after adrenalectomy.
    Wynn PC; Hauger RL; Holmes MC; Millan MA; Catt KJ; Aguilera G
    Peptides; 1984; 5(6):1077-84. PubMed ID: 6099558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.